A Study of the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia.
Clinical trial NCT04115319 · COMPLETED
Trial details
- NCT number
- NCT04115319
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-21
- Primary completion
- 2022-12-30
- Enrollment
- 305
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.